Viewing Study NCT00791232


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-30 @ 7:31 PM
Study NCT ID: NCT00791232
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2008-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module